RESEARCH-USE BIOSIMILAR ANTIBODY
Retifanlimab
Monoclonal antibody · IgG4
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA).
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-230
CATALOG NUMBERSC-BS-230
MOLECULAR WEIGHTApprox. 145.35 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA).
Retifanlimab is a recombinant research-use antibody directed against PDCD1.